根据血清泌乳素和肿瘤体积术前鉴别泌乳素瘤与无功能腺瘤
该回顾性研究分析76例泌乳素瘤和217例无功能腺瘤患者,发现泌乳素瘤体积与血清泌乳素水平强相关(r=0.831,p<0.001),而无功能腺瘤体积与泌乳素水平无显著相关(r=-0.020,p=0.773)。按腺瘤体积分组后,区分两种肿瘤的血清泌乳素截断值不同:≤0.5 cm³组为43.65 μg/L,>0.5至4 cm³组为60.05 μg/L,>4 cm³组为248.15 μg/L。
要点
- 泌乳素瘤体积与血清泌乳素水平强相关,而无功能腺瘤体积与泌乳素水平无显著相关。
- 区分泌乳素瘤与无功能腺瘤的血清泌乳素截断值应随腺瘤体积调整。
- 现行血清泌乳素阈值指南未考虑腺瘤体积,不能通用于所有体积的腺瘤。
核心结论
- 泌乳素瘤体积显著影响血清泌乳素水平,而无功能腺瘤体积不影响。
- 术前鉴别泌乳素瘤与无功能腺瘤时,腺瘤体积应作为确定因素。
- 现行血清泌乳素阈值指南不理想,不能通用于所有腺瘤体积。
研究设计与样本
- 回顾性分析连续患者,泌乳素瘤76例,无功能腺瘤217例。
- 按腺瘤体积分组比较两种病理,并进行受试者工作特征曲线分析。
主要发现
- 泌乳素瘤体积与血清泌乳素水平强相关(r=0.831,p<0.001)。
- 无功能腺瘤体积与血清泌乳素水平无显著相关(r=-0.020,p=0.773)。
- 按体积分组获得不同的血清泌乳素截断值:≤0.5 cm³组43.65 μg/L(AUC=0.951);>0.5至4 cm³组60.05 μg/L(AUC=0.949);>4 cm³组248.15 μg/L(AUC=1.0)。
关键数值与推荐
- ≤0.5 cm³组:血清泌乳素截断值43.65 μg/L(AUC=0.951)。
- >0.5至4 cm³组:血清泌乳素截断值60.05 μg/L(AUC=0.949)。
- >4 cm³组:血清泌乳素截断值248.15 μg/L(AUC=1.0)。
临床怎么用
- 术前鉴别泌乳素瘤与无功能腺瘤时,应结合腺瘤体积解读血清泌乳素水平。
- 可根据腺瘤体积分组采用相应的血清泌乳素截断值辅助诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prolactinoma and nonfunctioning adenoma (NFA) are the most common sellar pathologies, and both can present with hyperprolactinemia. There are no definitive studies analyzing the relationship between the sizes of prolactinomas and NFAs and the serum prolactin level. Current guidelines for serum prolactin level cutoffs to distinguish between pathologies are suboptimal because they fail to consider the adenoma volume. In this study, the authors attempted to describe the relationship between serum prolactin level and prolactinoma volume. They also examined the predictive value that can be gained by considering tumor volume in differentiating prolactinoma from NFA and provide cutoff values based on a large sample of patients. METHODS: A retrospective analysis of consecutive patients with prolactinomas (n = 76) and NFAs (n = 217) was performed. Patients were divided into groups based on adenoma volume, and the two pathologies were compared. RESULTS: A strong correlation was found between prolactinoma volume and serum prolactin level (r = 0.831, p < 0.001). However, there was no significant correlation between NFA volume and serum prolactin level (r = -0.020, p = 0.773). Receiver operating characteristic curve analysis of three different adenoma volume groups was performed and resulted in different serum prolactin level cutoffs for each group. For group 1 (≤ 0.5 cm3), the most accurate cutoff was 43.65 μg/L (area under the curve [AUC] = 0.951); for group 2 (> 0.5 to 4 cm3), 60.05 μg/L (AUC = 0.949); and for group 3 (> 4 cm3), 248.15 μg/L (AUC = 1.0). CONCLUSIONS: Prolactinoma volume has a significant impact on serum prolactin level, whereas NFA volume does not. This finding indicates that the amount of prolactin-producing tissue is a more important factor regarding serum prolactin level than absolute adenoma volume. Hence, volume should be a determining factor to distinguish between prolactinoma and NFA prior to surgery. Current serum prolactin threshold level guidelines are suboptimal and cannot be generalized across all adenoma volumes.
引用
- Burke WT, Penn DL, Castlen JP, et al. Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size. J Neurosurg. 2019. PMID: 31200381. doi:10.3171/2019.3.JNS19121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。